Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-246970
Filing Date
2024-10-30
Accepted
2024-10-30 06:24:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d903439d424b5.htm 424B5 9743
2 GRAPHIC g903439g1030080046444.jpg GRAPHIC 6049
  Complete submission text file 0001193125-24-246970.txt   19406
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-267795 | Film No.: 241407287
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)